Key Insights

Highlights

Success Rate

80% trial completion

Treatment Research

11 treatments under study, led by Cognis 100d Teligen Dr And Vr 100 He

Research Leaders

5 sponsors active, led by Boston Scientific Corporation

Related Conditions

Often studied with 11 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

16.7%

1 terminated out of 6 trials

Success Rate

80.0%

-6.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed with results

Key Signals

2 with results80% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed4
Unknown1
Terminated1

Trial Success Rate

80.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (6)

Research Network

Common Treatments

  • Cognis 100d Teligen Dr And Vr 100 He1
  • Home Monitoring Provided By Biotronik Icd And Crtd Devices1
  • Permanent Pacemaker Placement1
  • Implantable Defibrillator1
  • Reliance 4front Passive Fixation Lead Implantation1

Active Sponsors

  • Boston Scientific Corporation3
  • Baylor Research Institute1
  • Guidant Corporation1
  • Ruhr University Of Bochum1
  • Biotronik Se Co Kg1

Related Conditions

  • Ventricular Fibrillation5
  • Ventricular Tachycardia2
  • Intraventricular Conduction Delay1
  • Heart Failure1
  • Tachycardia1

Activity Timeline